247 related articles for article (PubMed ID: 29421784)
1. Complement Activation in Capillary Cerebral Amyloid Angiopathy.
Matsuo K; Shindo A; Niwa A; Tabei KI; Akatsu H; Hashizume Y; Akiyama H; Ayaki T; Maki T; Sawamoto N; Takahashi R; Oikawa S; Tomimoto H
Dement Geriatr Cogn Disord; 2017; 44(5-6):343-353. PubMed ID: 29421784
[TBL] [Abstract][Full Text] [Related]
2. Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype.
Tanskanen M; Lindsberg PJ; Tienari PJ; Polvikoski T; Sulkava R; Verkkoniemi A; Rastas S; Paetau A; Kiuru-Enari S
Neuropathol Appl Neurobiol; 2005 Dec; 31(6):589-99. PubMed ID: 16281907
[TBL] [Abstract][Full Text] [Related]
3. Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease.
Thal DR; Papassotiropoulos A; Saido TC; Griffin WS; Mrak RE; Kölsch H; Del Tredici K; Attems J; Ghebremedhin E
Acta Neuropathol; 2010 Aug; 120(2):169-83. PubMed ID: 20535486
[TBL] [Abstract][Full Text] [Related]
4. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
[TBL] [Abstract][Full Text] [Related]
5. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
[TBL] [Abstract][Full Text] [Related]
6. Relative paucity of tau accumulation in the small areas with abundant Abeta42-positive capillary amyloid angiopathy within a given cortical region in the brain of patients with Alzheimer pathology.
Oshima K; Akiyama H; Tsuchiya K; Kondo H; Haga C; Shimomura Y; Iseki E; Uchikado H; Kato M; Niizato K; Arai H
Acta Neuropathol; 2006 Jun; 111(6):510-8. PubMed ID: 16718347
[TBL] [Abstract][Full Text] [Related]
7. Capillary amyloid-β protein deposition in a population-based study (Vantaa 85+).
Mäkelä M; Paetau A; Polvikoski T; Myllykangas L; Tanskanen M
J Alzheimers Dis; 2016; 49(1):149-57. PubMed ID: 26444758
[TBL] [Abstract][Full Text] [Related]
8. Capillary CAA and perivascular Aβ-deposition: two distinct features of Alzheimer's disease pathology.
Attems J; Yamaguchi H; Saido TC; Thal DR
J Neurol Sci; 2010 Dec; 299(1-2):155-62. PubMed ID: 20850138
[TBL] [Abstract][Full Text] [Related]
9. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
Williams S; Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2005 Aug; 31(4):414-21. PubMed ID: 16008825
[TBL] [Abstract][Full Text] [Related]
10. Two types of sporadic cerebral amyloid angiopathy.
Thal DR; Ghebremedhin E; Rüb U; Yamaguchi H; Del Tredici K; Braak H
J Neuropathol Exp Neurol; 2002 Mar; 61(3):282-93. PubMed ID: 11895043
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of dyshoric capillary cerebral amyloid angiopathy.
Richard E; Carrano A; Hoozemans JJ; van Horssen J; van Haastert ES; Eurelings LS; de Vries HE; Thal DR; Eikelenboom P; van Gool WA; Rozemuller AJ
J Neuropathol Exp Neurol; 2010 Nov; 69(11):1158-67. PubMed ID: 20940625
[TBL] [Abstract][Full Text] [Related]
12. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
[TBL] [Abstract][Full Text] [Related]
13. Amyloid beta peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology.
Attems J; Lintner F; Jellinger KA
Acta Neuropathol; 2004 Apr; 107(4):283-91. PubMed ID: 14986026
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy.
Attems J; Jellinger KA; Lintner F
Acta Neuropathol; 2005 Sep; 110(3):222-31. PubMed ID: 16133541
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation.
Cho HS; Hyman BT; Greenberg SM; Rebeck GW
J Neuropathol Exp Neurol; 2001 Apr; 60(4):342-9. PubMed ID: 11305869
[TBL] [Abstract][Full Text] [Related]
16. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage.
McCarron MO; Nicoll JA; Stewart J; Ironside JW; Mann DM; Love S; Graham DI; Dewar D
J Neuropathol Exp Neurol; 1999 Jul; 58(7):711-8. PubMed ID: 10411341
[TBL] [Abstract][Full Text] [Related]
17. Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology--a pilot study.
Attems J; Jellinger KA
Acta Neuropathol; 2004 Feb; 107(2):83-90. PubMed ID: 14655019
[TBL] [Abstract][Full Text] [Related]
18. Sushi repeat-containing protein 1: a novel disease-associated molecule in cerebral amyloid angiopathy.
Inoue Y; Ueda M; Tasaki M; Takeshima A; Nagatoshi A; Masuda T; Misumi Y; Kosaka T; Nomura T; Mizukami M; Matsumoto S; Yamashita T; Takahashi H; Kakita A; Ando Y
Acta Neuropathol; 2017 Oct; 134(4):605-617. PubMed ID: 28478503
[TBL] [Abstract][Full Text] [Related]
19. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer's disease.
Hondius DC; Eigenhuis KN; Morrema THJ; van der Schors RC; van Nierop P; Bugiani M; Li KW; Hoozemans JJM; Smit AB; Rozemuller AJM
Acta Neuropathol Commun; 2018 Jun; 6(1):46. PubMed ID: 29860944
[TBL] [Abstract][Full Text] [Related]
20. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4.
Olichney JM; Hansen LA; Hofstetter CR; Lee JH; Katzman R; Thal LJ
Arch Neurol; 2000 Jun; 57(6):869-74. PubMed ID: 10867785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
